Chemical Compound

(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside

CAS Registry Number 19210-12-9
(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside 结构式
Primary record

(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside

库存
3,644 克
纯度
99.7 %
CAS
19210-12-9

化合物标识与属性

CAS
19210-12-9
PubChem CID
5281542
SMILES
C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)OC(=O)/C=C/C4=CC=CC=C4
Canonical SMILES
C[C@]1(OC(=O)/C=C/c2ccccc2)C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]21

名称与同义词

  • Harpagoside
  • 19210-12-9
  • E-harpagoside
  • Harpagosid
  • Laterioside
  • Harpaside
  • Harpagoside CRS
  • 8KGS1DC5ZU
  • AC1NQYLY
  • UNII-8KGS1DC5ZU
  • Harpagoside (Standard)
  • RefChem:38185
  • Prestwick3_000988
  • BSPBio_001055
  • HARPAGOSIDE [WHO-DD]
  • MLS002154086
  • MLS002473324
  • SCHEMBL893387
  • 3,4-Dichlorophenylboronic acid
  • C24H30O11
  • KVRQGMOSZKPBNS-FMHLWDFHSA-N
  • MFCD00017415
  • BPBio1_001161
  • CHEBI:5625
  • CHEMBL516702
  • DTXSID101032528
  • MEGxp0_000469
  • orb1300175
  • Harpagoside, analytical standard
  • ACon0_000056
  • ACon1_000134
  • EINECS 242-881-6
  • ERK5-4I12
  • HY-N0396R
  • DTXCID501517542
  • HMS2098E17
  • HMS2231N12
  • HY-N0396
  • ZINC8214398
  • HARPAGOSIDE (REFERENCE GRADE)
  • NP3892
  • s9171
  • WS1531
  • AKOS015896715
  • ACN-035401
  • CCG-269650
  • CID5281542
  • EBC-217031
  • LMPR0102070010
  • MH08976
  • WS 1531
  • C24-H30-O11
  • NCGC00179325-01
  • NCGC00179325-02
  • NCGC00179325-04
  • NCGC00179325-05
  • 4CN-1249
  • AC-34268
  • AS-56071
  • J16.076H
  • SC-19416
  • SMR001233395
  • AB00513986
  • CS-0008931
  • FT-0626864
  • FT-0776572
  • NS00101087
  • V0696
  • A13953
  • C09783
  • H10494
  • EN300-7357122
  • 210H129
  • A880338
  • [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
  • I07-0170
  • BRD-K07996107-001-01-7
  • BRD-K07996107-001-03-3
  • Harpagoside, primary pharmaceutical reference standard
  • Q25099323
  • (1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate
  • Harpagoside, European Pharmacopoeia (EP) Reference Standard
  • Harpagoside, 98%, from Harpagophytum procumbens D.C. - 10MG 10mg
  • (1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyran-7-yl (2E)-3-phenylprop-2-enoate
  • [1S-[1alpha,4aalpha,5alpha,7alpha(E),7aalpha]]-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-beta-D-glucopyranoside
  • ((1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-1,5,6,7a-tetrahydrocyclopenta(c)pyran-7-yl) (E)-3-phenylprop-2-enoate
  • (1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside
  • (1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside
  • .BETA.-D-GLUCOPYRANOSIDE, (1S,4AS,5R,7S,7AS)-1,4A,5,6,7,7A-HEXAHYDRO-4A,5-DIHYDROXY-7-METHYL-7-(((2E)-1-OXO-3-PHENYL-2-PROPENYL)OXY)CYCLOPENTA(C)PYRAN-1-YL
  • [(1S)-1,4a,5,6,7,7aalpha-Hexahydro-4aalpha,5alpha-dihydroxy-7-methyl-7alpha-[[(E)-1-oxo-3-phenyl-2-propenyl]oxy]cyclopenta[c]pyran-1alpha-yl]beta-D-glucopyranoside
  • [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
  • 242-881-6
  • 70206-27-8
  • b-D-Glucopyranoside,(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl
  • beta-D-Glucopyranoside, 1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-((1-oxo-3-phenyl-2-propenyl)oxy)cyclopenta(c)pyran-1-yl, (1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-